Protara Therapeutics (TARA) Times Interest Earned (2013 - 2014)

Protara Therapeutics (TARA) has reported Times Interest Earned for 14 consecutive years, with -$2.22 the latest figure, recorded in Q1 2026.

• In Q1 2026, Times Interest Earned rose 33.61% year-over-year to -$2.22; the TTM figure through Mar 2026 stood at -$7.92 (up 34.92% YoY), while the FY2025 annual figure was -$0.77, down 13.88% from the prior year.
• Times Interest Earned grew to -$2.22 in Q1 2026 per TARA's latest filing, from -$53.44 in the prior quarter.
• Across five years, Times Interest Earned topped out at -$2.22 in Q1 2026 and bottomed at -$119.0 in Q4 2022.
• Historically, Times Interest Earned has averaged -$21.54 across 5 years, with a median of -$7.01 in 2022.
• On a YoY basis, Times Interest Earned climbed as much as 97.45% in 2022 and fell as far as 2565.33% in 2022.
• Protara Therapeutics' Times Interest Earned stood at -$119.0 in 2022, then soared by 61.18% to -$46.2 in 2023, then advanced by 6.68% to -$43.11 in 2024, then slipped by 23.97% to -$53.44 in 2025, then jumped by 95.85% to -$2.22 in 2026.
• Business Quant data shows TARA's Times Interest Earned at -$2.22 in Q1 2026, -$53.44 in Q4 2025, and -$2.92 in Q3 2025.